| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |